T CELL AND NK CELL ENGAGERS

The present disclosure pertains to T cell and/or NK cell engaging agents, and uses thereof. In some embodiments, the present disclosure provides bispecific antibody molecules or antigen-binding fragments thereof comprising (i) a first antigen-binding domain that selectively binds to transmembrane an...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: RAUSCH, Matthew, ETEMAD-GILBERTSON, Bijan
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator RAUSCH, Matthew
ETEMAD-GILBERTSON, Bijan
description The present disclosure pertains to T cell and/or NK cell engaging agents, and uses thereof. In some embodiments, the present disclosure provides bispecific antibody molecules or antigen-binding fragments thereof comprising (i) a first antigen-binding domain that selectively binds to transmembrane and immunoglobulin domain containing 2 (TMIGD2); and (ii) a second antigen-binding domain that selectively binds to at least one tumor-associated antigen (TAA). Such agents disclosed herein (e.g., bispecific antibody molecules or antigen-binding fragments thereof) can be used in methods of treating a subject having a disease, disorder, or condition and/or modulating an immune response in a subject.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2023217006A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2023217006A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2023217006A13</originalsourceid><addsrcrecordid>eNrjZJAOUXB29fFRcPRzUfDzhrBd_dwd3V2DgnkYWNMSc4pTeaE0N4Oym2uIs4duakF-fGpxQWJyal5qSbxjqJGBkbGRobmBgZmjoTFxqgCNtSCs</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>T CELL AND NK CELL ENGAGERS</title><source>esp@cenet</source><creator>RAUSCH, Matthew ; ETEMAD-GILBERTSON, Bijan</creator><creatorcontrib>RAUSCH, Matthew ; ETEMAD-GILBERTSON, Bijan</creatorcontrib><description>The present disclosure pertains to T cell and/or NK cell engaging agents, and uses thereof. In some embodiments, the present disclosure provides bispecific antibody molecules or antigen-binding fragments thereof comprising (i) a first antigen-binding domain that selectively binds to transmembrane and immunoglobulin domain containing 2 (TMIGD2); and (ii) a second antigen-binding domain that selectively binds to at least one tumor-associated antigen (TAA). Such agents disclosed herein (e.g., bispecific antibody molecules or antigen-binding fragments thereof) can be used in methods of treating a subject having a disease, disorder, or condition and/or modulating an immune response in a subject.</description><language>eng</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; HUMAN NECESSITIES ; HYGIENE ; INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; PHYSICS ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPIRITS ; TESTING ; VINEGAR ; WINE</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20240801&amp;DB=EPODOC&amp;CC=AU&amp;NR=2023217006A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25562,76317</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20240801&amp;DB=EPODOC&amp;CC=AU&amp;NR=2023217006A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>RAUSCH, Matthew</creatorcontrib><creatorcontrib>ETEMAD-GILBERTSON, Bijan</creatorcontrib><title>T CELL AND NK CELL ENGAGERS</title><description>The present disclosure pertains to T cell and/or NK cell engaging agents, and uses thereof. In some embodiments, the present disclosure provides bispecific antibody molecules or antigen-binding fragments thereof comprising (i) a first antigen-binding domain that selectively binds to transmembrane and immunoglobulin domain containing 2 (TMIGD2); and (ii) a second antigen-binding domain that selectively binds to at least one tumor-associated antigen (TAA). Such agents disclosed herein (e.g., bispecific antibody molecules or antigen-binding fragments thereof) can be used in methods of treating a subject having a disease, disorder, or condition and/or modulating an immune response in a subject.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PHYSICS</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPIRITS</subject><subject>TESTING</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJAOUXB29fFRcPRzUfDzhrBd_dwd3V2DgnkYWNMSc4pTeaE0N4Oym2uIs4duakF-fGpxQWJyal5qSbxjqJGBkbGRobmBgZmjoTFxqgCNtSCs</recordid><startdate>20240801</startdate><enddate>20240801</enddate><creator>RAUSCH, Matthew</creator><creator>ETEMAD-GILBERTSON, Bijan</creator><scope>EVB</scope></search><sort><creationdate>20240801</creationdate><title>T CELL AND NK CELL ENGAGERS</title><author>RAUSCH, Matthew ; ETEMAD-GILBERTSON, Bijan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2023217006A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2024</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PHYSICS</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPIRITS</topic><topic>TESTING</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>RAUSCH, Matthew</creatorcontrib><creatorcontrib>ETEMAD-GILBERTSON, Bijan</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>RAUSCH, Matthew</au><au>ETEMAD-GILBERTSON, Bijan</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>T CELL AND NK CELL ENGAGERS</title><date>2024-08-01</date><risdate>2024</risdate><abstract>The present disclosure pertains to T cell and/or NK cell engaging agents, and uses thereof. In some embodiments, the present disclosure provides bispecific antibody molecules or antigen-binding fragments thereof comprising (i) a first antigen-binding domain that selectively binds to transmembrane and immunoglobulin domain containing 2 (TMIGD2); and (ii) a second antigen-binding domain that selectively binds to at least one tumor-associated antigen (TAA). Such agents disclosed herein (e.g., bispecific antibody molecules or antigen-binding fragments thereof) can be used in methods of treating a subject having a disease, disorder, or condition and/or modulating an immune response in a subject.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_AU2023217006A1
source esp@cenet
subjects BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PHYSICS
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
TESTING
VINEGAR
WINE
title T CELL AND NK CELL ENGAGERS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T15%3A26%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=RAUSCH,%20Matthew&rft.date=2024-08-01&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2023217006A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true